FDA Approves UCB, Inc., Sanofi-Aventis (France)'s XYZAL(R) For Use In ...

Full story: BioSpace

UCB and sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration has approved XYZAL for children age six months and older for the relief of symptoms of perennial allergic rhinitis and chronic idiopathic urticaria and for children age two years and older for symptoms of seasonal allergic rhinitis .

Post

Leave a Comment

Email me Biology news. Learn more

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Biology Discussions

Topic	Updated	Last By	Comments
Should evolution be taught in high school? (Feb '08)	5 min	Abbey Yoyo	31677
8th ed. Biology by Campbell Test Bank	18 min	dough_boii	3
campbell and reece biology 7e and 8e testbank f...	21 min	dough_boii	2
Maternal-Child Nursing 3rd edition Mckinney Tes...	21 min	Jane	19
(Bobo) Next FREE Biology Campbell testbank	24 min	stingray	2
Intelligent Design: Coming To A State Legislatu... (May '08)	36 min	shinningelectr0n	37252
ATI nursing Test Bank	1 hr	abella	154